Med-IQ CME Courses

Primary care clinicians and endocrinologists play a critical role in identifying and managing metabolic dysfunction-associated steatohepatitis (MASH) before it progresses. Results from a Med-IQ survey, however, revealed that approximately half of the respondents screen only 50% or fewer of their patients with obesity or type 2 diabetes. Patients with these conditions or other risk factors, such as metabolic syndrome, dyslipidemia, or elevated liver enzymes, should be screened using noninvasive tools like FIB-4, transient elastography (FibroScan), ELF, or VCTE.

Although lifestyle modification remains the cornerstone of treatment, pharmacologic options such as GLP-1 receptor agonists, pioglitazone, and resmetirom may be appropriate based on individual risk profiles. Most patients can be effectively managed in primary care or endocrinology settings, with hepatology referral recommended for patients with a high risk of advanced fibrosis.

In this accredited CME activity, meet a patient who presents with right lower extremity pain with exertion. What will your next steps be in the management of this patient? This activity will discuss modifiable cardiovascular risk factors, sex-specific markers of risk, and management of diabetes in the presence of cardiovascular disease. The activity starts with an introduction to a patient scenario, followed by a case-related question and brief answer explanations.

Early identification of atypical motor patterns is crucial for timely intervention and optimizing developmental outcomes in infants. A simple yet effective method for assessing these patterns involves observing the baby during a 30-second, 4-position exam. This examination includes careful observation of the infant in the following positions:

* Supine: Note posture, spontaneous movements, and interaction with the environment.

* Horizontal Suspension: Observe head control, trunk extension, and limb movements against gravity.

* Pull to Sit: Assess head lag, trunk activation, and ability to assist with the movement.

* Prone: Evaluate head lifting, weight-bearing through the arms, and early mobility attempts. Gain valuable insights and download resources through this complimentary CME/CE course

Guideline updates and recommendations are key patient management tools for cardiac care. This accredited educational activity is designed for primary care physicians and presents a curated series of posts and data centered on the updated AHA/ACC/HFSA guidelines for the management of heart failure. It provides a comprehensive review of the latest evidence-based recommendations, critically examines the clinical trial data behind these guidelines, and underscores the clinical significance of early initiation of guideline-directed medical therapies and timely specialist referral to optimize patient outcomes in heart failure care.

Sacroiliac joint pain is common, accounting for 10% to 38% of cases of chronic low back pain. In this educational activity, learn about the diagnosis and management of patients with sacroiliac pain, including when to consider minimally invasive robotic surgery.

This CME activity discusses the diagnosis and treatment of ATTR-CM and highlights key updates on ATTR-CM treatment from the ACC 2025 annual meeting.

This accredited activity for primary care providers discusses optimal therapy for patients with epilepsy. Specifically, it focuses on the importance of considering referral to epilepsy centers, especially when seizures are not well controlled. This activity also aims to educate primary care providers on how surgical evaluation and treatment may help patients achieve optimal outcomes.

This brief accredited CME activity uses a quiz-based microlearning platform to present a patient case scenario and related questions, allowing clinicians to quickly test their knowledge of the essential components of evaluating patients with metastatic colorectal cancer to the liver and selecting an appropriate treatment strategy. They can then compare their responses with those of their peers. Rationale for correct answers and key educational takeaways are provided via video clips from expert faculty.

Using a quiz-based format, this accredited CME activity offers a brief, interactive microlearning experience centered around a clinical case scenario, enabling clinicians to quickly test their understanding of weight-related eligibility criteria for kidney transplantation, compare their answers with peer responses, and gain expert insights through video commentary. Faculty explore how obesity affects transplant candidacy, evaluation strategies, and potential interventions to optimize patients for transplant, as well as provide key takeaways to support informed, patient-centered clinical decisions.

In this #CME #MedX, get the latest guidance on managing hypertrophic cardiomyopathy (HCM), including confirming an obstructive HCM (oHCM) diagnosis, integrating recent clinical information on cardiac myosin inhibitor treatments, and addressing patients’ concerns and questions about living with HCM.

In this brief 15-minute activity, you will:

– Follow the case of a patient who presents with foot drop and no other medical conditions
– Choose optimal management approaches by answering nongraded questions within the activity (answers are collected for informational purposes only and used to assess the effectiveness of this educational activity)
– See how your answers compare with those of your peers
– View video clips providing expert insights

In this MedX activity, Robert Haddad, MD, explores the latest clinical data for emerging novel therapies for recurrent/metastatic head and neck squamous cell carcinoma with an emphasis on results presented at ESMO 2025.

This CME activity discusses the diagnosis and treatment of ATTR-CM and highlights key updates on ATTR-CM treatment presented at the HFSA Annual Scientific Meeting 2025 and AHA Scientific Sessions 2025.

In this 15-minute activity, meet 2 patients with arm pain, one of whom also presents with neck pain. How would you manage these patients? This accredited activity uses an interactive, quiz-driven microlearning format to explore clinical case scenarios with targeted questions, allowing clinicians to quickly assess their knowledge. Clinicians can compare their responses with those of their peers and receive expert guidance through video commentary.

This accredited activity reviews advancements in lung transplant surgery, with a focus on robotic lung transplant and ex vivo lung perfusion.

In this CME activity, discover the latest information on investigational factor XI/XIa inhibitors, including results from completed clinical trials and news about ongoing clinical trials, to explore their potential role in managing stroke risk in patients with atrial fibrillation (AF).

Expert faculty dive into the rapidly evolving world of BCMA-directed bispecific antibodies for multiple myeloma, exploring practical strategies to bring these cutting-edge therapies into everyday clinical care.

This series was developed by Boston University Chobanian & Avedisian School of Medicine in collaboration with the American Academy of Physician Associates, the Association of PAs in Oncology, HealthTree Foundation, and Med-IQ.

Faculty discusses the prevention and management of cytokine release syndrome (CRS), immune effector cell–associated neurotoxicity syndrome (ICANS), and infections in patients with relapsed/refractory multiple myeloma treated with BCMA-directed bispecific antibodies.

This series was developed by Boston University Chobanian & Avedisian School of Medicine in collaboration with the American Academy of Physician Associates, the Association of PAs in Oncology, HealthTree Foundation, and Med-IQ.

Discover how communities of practice are expanding access to bispecific antibodies, as faculty share practical guidance on starting these therapies in community settings and smoothly transitioning patients from academic centers to local care.

This series was developed by Boston University Chobanian & Avedisian School of Medicine in collaboration with the American Academy of Physician Associates, the Association of PAs in Oncology, HealthTree Foundation, and Med-IQ.

Patient advocate and HealthTree Foundation CEO Jenny Ahlstrom shares fresh survey insights into the physical, emotional, and social quality-of-life experiences of patients treated with bispecific antibodies, while spotlighting key educational, financial, and community resources designed to support them.

This series was developed by Boston University Chobanian & Avedisian School of Medicine in collaboration with the American Academy of Physician Associates, the Association of PAs in Oncology, HealthTree Foundation, and Med-IQ.